TET2 and angioimmunoblastic T-cell lymphoma: Nonetheless, it remains to be investigated whether the above finding represents a common feature of AITL, or some of the minor T‐cell clones might be the consequence of immune reaction to immunodeficiency and EBV reactivation in patients with AITL, rather than due to TET2 or DNMT3A mutation (Figure 6).